Omneity® Pellets
All-In-One Vitamin & Mineral Pellet
Topic:Clinical Study
Clinical studies in equine research involve the systematic investigation of health and disease in horses through structured scientific methods. These studies aim to evaluate the safety and efficacy of treatments, understand disease mechanisms, and improve veterinary care practices. Clinical studies can include randomized controlled trials, observational studies, and case-control studies. They may focus on various aspects such as pharmacokinetics, therapeutic interventions, and diagnostic techniques. This page compiles peer-reviewed research studies and scholarly articles that explore the design, implementation, and findings of clinical studies in equine medicine, providing insights into their impact on horse health and veterinary practices.
Influence of azaperone/metomidate anaesthesia on blood biochemistry in the horse. Ponies were anaesthetized by administration of the ataractic, azaperone (0 · 2–0 · 8 mg/kg), in combination with the hypnotic, metomidate (3 · 5 mg/kg). Changes in blood biochemistry were measured during and following the course of action of these drugs. In control experiments, azaperone (0 · 4 and 0 · 8 mg/kg) was administered alone to other ponies. There were no significant changes in blood glucose concentration in either circumstance. Blood lactate and pyruvate concentrations and lactate/pyruvate ratio were not altered significantly by azaperone. However, moderate increases in lactat...
Experience of the efficacy of equine influenza vaccinations. In 1974, a very extensive influenza/A/equi 2 epidemic broke out in the Finnish horse population. To study the efficacy of influenza vaccinations a questionnaire was sent after the epidemic to all Finnish veterinarians. The answer material was selected to contain only stables which had had clinically typical cases. The material consisted 234 unvaccinated and 629 vaccinated horses. In the latter group 466 horses were vaccinated adequately. The results of the study showed that of the unvaccinated horses 212 (91%) and of the adequately vaccinated horses only 42 (9.4%) contracted clinically typical...
Fluprostenol in mares: clinical trials for the treatment of infertility. Fluprostenol (ICI 81,008) is a 16-aryloxyprostaglandin, structurally related to PGF2alpha. It is a highly potent luteolytic agent, being effective in thoroughbred mares at a single intramuscular dose of 250 mug and having a wide margin of safety in this species. A total of 941 mares have been treated with fluprostenol in an international trial, for various forms of infertility associated with abnormal persistence of luteal function. These mares were selected for treatment on the basis of clinical examination and 760 (approximately 80 per cent) responded fluprostenol by showing oestrus within s...
Estimation of cardiac output in the horse by thermodilution techniques. An evaluation and comparison of thermodilution technique with dye dilution technique was made in the computation of cardiac output in 39 conscious adult horses (av body wt, 450 kg). Estimation of cardiac output by thermodilution was found to compare favorably with values obtained from dye dilution when a volume of 30 to 40 ml at a temperature of 0 C was used. Difficulties in obtaining accurate thermodilution curves in the horse seem predominantly associated with errors in mixing and observation.
The influence of hepatic microsomal amidopyrine demethylase activity on halothane hepatotoxicity in the horse. The hepatotoxic effect of oral halothane in the horse is increased by pretreatment with phenobarbitone or DDT but not by chlorpromazine. Phenobarbitone and DDT increase the activity of hepatic amidopyrine N-demethylase but chlorpromazine does not. Carbon disulphide protects the liver of the horse against halothane.
Studies on the development and chemotherapy of larvae of Parascaris equorum (Nematoda: Ascaridoidea) in experimentally and naturally infected foals. Experimentally induced infections of Parascaris equorum in worm-free pony foals required 14 to 17 days for migration of the larvae through the liver and lungs, and 79 to 110 days to become gametogenically functional. Treatment of experimentally infected or naturally exposed foals during the parenteral phase of development, using levamisole at 8 mg/kg, a mixture of levamisole at 8 mg/kg plus piperazine at 88 mg base equivalent/kg, or dl-tetramisole at 10 mg/kg, was quite efficacious in (1) reducing the number of P. equorum larvae recovered from the small intestines of the foals at necropsy, or ...
Observations on the intraarticular use of corticosteroids in the racing thoroughbred. A project to determine if intraarticular corticosteroid therapy was deleterious to the racing Thoroughbred was carried out in the 1971, 1972, and 1973 racing seasons. Of 22 horses available for follow-up examination, 6 had radiographic evidence of deterioration; 1 of these was destroyed because of probable corticosteroid-induced arthropathy. The remaining 16 horses did not have any evidence of deterioration. One of the 16, a stakes winner, had been given 12 injections into the left front fetlock during the 3-year period. It was concluded that if proper and careful aftercare is adhered to, intr...
Villonodular synovitis of the equine metacarpophalangeal joint. Villonodular synovitis was diagnosed as the cause of lameness in 14 horses. The diagnosis was based on the history, clinical signs, and arthrographic findings. Treatment consisted of surgical excision and radiation therapy. The response to treatment was favorable in 13 horses.
Critical tests of anthelmintic activity of a paste formulation of thiabendazole in horses. Critical tests of the activity on large strongyles, ascarids, mature pinworms, and bots were carried out in 11 horses intraorally treated with a paste formulation of thiabendazole. The dose level of 44 mg/kg was administered to 3 horses, and the dose level of 88 mg/kg to 8 horses. Removals of Strongylus vulgaris and mature Oxyuris equi were 100% at the 2 dose levels, and efficacy against Strongylus edentatus varied from 95 to 99% and 89 to 100% for the 44- and the 88-mg/kg dose levels, respectively. Strongylus equinus was completely removed from the 1 infected horse treated at the dose level o...
Observations on growth plates in limbs of foals. Observations were made which may be related to growth plate disorders. They included irregularity and thickening of the growth plate bridging of the plate by bony spicules, distortion of the plate adjacent to foci of fusion, and metaphyseal lipping. These observations are very similar to those found in "epiphysitis." The question had to be asked, where these normal foals or did they have sub-clinical "epiphysitis"?
Levels of luteinizing hormone and progesterone during the estrous cycle and early pregnancy in mares. Jugular venous blood was collected from 16 mares at daily intervals throughout the estrous cycle. Twelve of these mares were bred to fertile stallions. Of the twelve, four were palpated daily throughout the estrous cycle, four were palpated daily during estrus and four were not palpated. The remaining four mares were not palpated or bred and blood samples were collected at 6-h intervals during estrus. Serum was harvested from all blood samples by centrifugation. The serum samples were analyzed for luteinizing hormone (LH) and/or progesterone by radioimmunoassay. Levels of LH in serum increased...
Immunity to equine herpesvirus type 1 (rhinopneumonitis): in vitro lymphocyte response. Twenty-two ponies were examined for serum-neutralizing (SN) antibody to equine herpesvirus type 1 and for in vitro lymphocyte transformation in the presence of viral antigen. Six ponies had undetectable levels of neutralizing antibody (titer less than 1:2) and had lymphocytes which did not respond in culture with viral antigen (stimulation index less than 2.0). Four ponies which had SN antibody to equine herpesvirus type 1 did not manifest lymphocyte transformation in vitro. The 12 remaining seropositive ponies had lymphocyte transformation with viral antigen in vitro (stimulation indexes from...
Luteolysis following carotid or ovarian arterial injection of prostaglandin F2alpha in mares. On the day of ovulation (Day 0), 20 pony mares were randomly assigned to one of five groups (4 mares/group) which were given intracarotid arterial (ICA) and intraovarian arterial (IOA) injections on Day 7 as follows: 1) vehicle ICA, vehicle IOA (control); 2) .125 mg PGF2α ICA, vehicle IOA; 3) vehicle ICA, .125 mg PGF2α IOA; 4) .250 mg PGF2α ICA, vehicle IOA; or 5) vehicle ICA, .250 mg PGF2α IOA. Peripheral plasma progesterone and LH concentrations were determined for 0 (pretreatment) and .1, .25, .50, .75, 1, 6, 12, 24, 48, 72 and 96 h posttreatment. The intervals (days) from treatment to ...
